🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Alcoholic Liver Disease (ALD)

Comparison of ALD, NASH, and Healthy Control Patients NCT03224949n/a1 site📍 Cleveland The Cleveland Clinic · Tests: Blood draw A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites📍 Basildon📍 Bournemouth📍 Bristol King's College London · Tests: Encapsulated FMT, Placebo Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers NCT03308916NA1 site📍 Odense Maja Thiele · Tests: transient elastography, Enhanced liver fibrosis test, Indirect serum markers of liver fibrosis, Direct serum markers of… Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients NCT05699018NA13 sites📍 Angers📍 Angers📍 Baugé-en-Anjou University Hospital, Angers · Tests: eLIFT A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD) NCT07791043Phase 24 sites📍 Topeka📍 Fort Worth📍 San Antonio GlaxoSmithKline · Tests: Efimosfermin alfa, Placebo Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis NCT07169526n/a1 site📍 Hanover Hannover Medical School Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) NCT07428538Phase 392 sites📍 Birmingham📍 Mobile📍 Phoenix Bausch Health Americas, Inc. · Tests: Larsucosterol, Placebo A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease NCT06613698Phase 2140 sites📍 Chandler📍 Phoenix📍 Tucson GlaxoSmithKline · Tests: GSK4532990, Placebo Elastography-based Brief Alcohol Intervention in Hospitalized Individuals NCT07637539NA8 sites📍 Bergen📍 Drammen📍 Levanger Oslo University Hospital · Tests: Elastography-based brief alcohol intervention Identification of Hepatic Fibrosis Using 4D-MRI NCT05385237NA2 sites📍 Liestal📍 Basel University Hospital, Basel, Switzerland · Tests: 4D-MRI
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy